In type 1 diabetes, the EXTEND Phase II trial of tocilizumab, a monoclonal antibody against the IL-6 receptor, was recently completed (ClinicalTrials.gov registration no
In this context, postbiotics are more plausibly positioned not as primary weight-loss interventions, but as nutritional strategies that may be continued after GLP-1based pharmacotherapy to support metabolic stability, mitigate weight regain, and preserve lean mass during the post-treatment phase ( From a clinical nutrition perspective, postbiotics should not be positioned as weight-loss agents, nor as substitutes for pharmacological GLP-1 receptor agonists
Opitac Pharmaceutical-Grade Glutathione Not all glutathione is equal
The GIP component is thought to further improve how the body breaks down sugar and fat, while potentially reducing the nausea often associated with GLP-1 medications
Stick with low-fat plain kefir: Kefir comes in lots of flavors and can have varying levels of fat, not to mention added sugars